A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgery

Auteurs

P. Pautier, A. Floquet, C. Chevreau, N. Penel, C. Guillemet, C. Delcambre, D. Cupissol, F. Selle, N. Isambert, S. Piperno-Neumann, E. Saada-Bouzid, F. Bertucci, E. Bompas, J. Alexandre, O. Collard, V. Lebrun-Ly, P. Soulier, M. Toulmonde, A. Le Cesne, B. Lacas, F. Duffaud